logo

For the Inventor, By the Inventor

Tianjin, China

Lida Tang

This inventor holds 12 USPTO granted patents and 2 published patent applications and 8 EPO patents. Top assignees: Tianjin Institute of Pharmaceutical Research, Tianjin Institute of Pharmaceutical Research Co., Ltd.. Active years: 2010-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lida Tang. Retrieved from https://idiyas.com/inventor/lida-tang

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 

% Patents Active = 50.0

 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:

goldMedal8 out of 10 
 
Tianjin Institute of Pharmaceutical Research
 patents
silverMedal4 out of 5 
 
Tianjin Institute of Pharmaceutical Research Co., Ltd.
 patents

Years Active: 2010-2022

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 11466025 - Thienopyridine derivatives containing unsaturated aliphatic olefinic bond, preparation method and use thereof (2022-10-11),
2. 11149013 - Crystal form of urate transporter 1 inhibitor and preparation method and use thereof (2021-10-19),
3. 11091448 - Method for preparing urate transporter 1 inhibitor (2021-08-17),
4. 10584104 - Carboxylic acid URAT1 inhibitor containing diarylmethane structure, preparation method and use thereof (2020-03-10),
5. 10294259 - Phenyl c-glucoside derivative containing deoxyglucose structure, preparation method and use thereof (2019-05-21),
6. 9505734 - Phenyl C-glucoside derivative containing deoxyglucose structure, preparation method and use thereof (2016-11-29),
7. 9216169 - Pharmaceutical composition comprising candesartan or ester thereof and chlortalidone, and use thereof (2015-12-22),
8. 9062087 - Phenyl C-glucoside derivatives, preparation methods and uses thereof (2015-06-23),
9. 8835134 - Cycloastragenol monoglucoside, preparation, pharmaceutical composition and application thereof (2014-09-16),
10. 8809366 - Thienopyridine ester derivative containing cyano group, preparation method, use and composition thereof (2014-08-19),
11. 8481577 - Amide thiazole derivative, preparation method and uses thereof (2013-07-09),
12. 7790759 - Glycyrrhetinic acid-30-amide derivatives and their use (2010-09-07),

Title: Lida Tang: Innovator in Pharmaceutical Chemistry

Introduction

Lida Tang, based in Tianjin, China, is a prominent inventor with a remarkable portfolio of 12 patents. His groundbreaking work primarily focuses on pharmaceutical chemistry, with significant contributions to compounds that enhance therapeutic effects while minimizing side effects.

Latest Patents

Lida Tang's latest patents consist of innovative compounds and their applications. One notable patent is for "Thienopyridine derivatives containing unsaturated aliphatic olefinic bond," which introduces a compound with a unique structure designed to tackle important medical issues. This invention addresses clopidogrel resistance, severe hemorrhagic side effects, and the stability of existing compounds, positioning it as a potential ADP receptor antagonist antiplatelet agent with enhanced therapeutic efficacy and stability.

Another recent patent involves a "Crystal form of urate transporter 1 inhibitor," which highlights a stable crystalline form of the inhibitor. This development is aimed at improving the purity and storage stability of the compound, making it suitable for pharmaceutical raw material use.

Career Highlights

Throughout his career, Lida Tang has contributed significantly to pharmaceutical research. He has worked with reputable institutions such as the Tianjin Institute of Pharmaceutical Research and Tianjin Institute of Pharmaceutical Research Co., Ltd. His dedication to innovation in the pharmaceutical industry is reflected in his research and patent output.

Collaborations

Lida Tang has collaborated with notable colleagues in the field, including Weiren Xu and Yuli Wang. These partnerships have facilitated the development of his innovative ideas into patented inventions, further strengthening his impact in pharmaceutical research.

Conclusion

Lida Tang stands out as a distinguished inventor whose contributions to pharmaceutical chemistry have led to the development of crucial compounds for medical applications. His extensive patent portfolio and collaborations reflect his commitment to advancing healthcare solutions through innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…